Canagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, canagliflozin became the first SGLT2 inhibitor to be approved in the United States.
Nomura, Sumihiro; Sakamaki, Shigeki; Hongu, Mitsuya; Kawanishi, Eiji; Koga, Yuichi; Sakamoto, Toshiaki; Yamamoto, Yasuo; Ueta, Kiichiro; Kimata, Hirotaka; Nakayama, Keiko; Tsuda-Tsukimoto, Minoru. Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Co-transporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Journal of Medicinal Chemistry. Volume 53. Issue 17. Pages 6355-6360. Journal. (2010).
Metil, Dattatray S.; Sonawane, Swapnil P.; Pachore, Sharad S.; Mohammad, Aaseef; Dahanukar, Vilas H.; McCormack, Peter J.; Reddy, Ch. Venkatramana; Bandichhor, Rakeshwar. Synthesis and Optimization of Canagliflozin by Employing Quality by Design (QbD) Principles. Organic Process Research & Development. Volume 22. Issue 1. Pages 27-39. Journal; Online Computer File. (2018).
Henschke, Julian P.; Wu, Ping-Yu; Lin, Chen-Wei; Chen, Shi-Feng; Chiang, Pei-Chen; Hsiao, Chi-Nung. β-Selective C-Arylation of Silyl Protected 1,6-Anhydroglucose with Arylalanes: The Synthesis of SGLT2 Inhibitors. Journal of Organic Chemistry. Volume 80. Issue 4. Pages 2295-2309. Journal; Online Computer File. (2015).
Patkar, Laxmikant Narahari; Mondkar, Harish Kashinath; Deshpande, Manoj Madhukarrao; Wagh, Yogesh Sambhaji; Vengurlekar, Rupesh Sudhir; Jadhav, Rupesh Sheshrao. Synthesis and purification of canagliflozin. Assignee USV Private Limited, India. IN 201621009743. (2017).
Vellanki, Siva Ram Prasad; Balusu, Raja Babu; Pilli, Ramakrishna; Javvaji, Rajeswara Rao; Annadasu, Ankama Nayudu. Process for the preparation of canagliflozin. Assignee Mylan Laboratories Ltd., India. IN 2014CH04366. (2016).
Liu, Yongjian; Wu, Mingjun; Xiao, Xinqiang; Tang, Guijun; Huang, Yinghao; Zhang, Rongxia; Li, Haihong. Method for preparation of 2,5-disubstituted thiophene compounds and their use in the preparation of canagliflozin. Assignee Topharman Shanghai Co., Ltd., Peop. Rep. China; Topharman Shandong Co., Ltd.. WO 2011079772. (2011).
